Search - tctmd.com

Displaying 981 - 1000 of 1302

Sort: Relevancy | Date

Presentation TCT 2017

Bioresorbable Scaffolds in a Coronary CTO

Presenter: Teguh Santoso, Yoshito Yamamoto

October 30, 2017

Presentation TCT 2017

Industry Perspective on HBD

Presenter: Fumiaki Ikeno, Yuka Suzuki, Neal Fearnot

October 30, 2017

Presentation TCT 2017

Case #3: Double CTO in AMI With Cardiogenic Shock

Presenter: Teguh Santoso, Yoshito Yamamoto, Makoto Sekiguchi

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey V: Addressing Complications and Follow-up

Presenter: Martina Kelly Speight, Amy E. Simone

October 30, 2017

Presentation TCT 2017

Case #2: Wire Gone Weird

Presenter: Teguh Santoso, Yoshito Yamamoto, Wirash Kehasukcharoen

October 30, 2017

Presentation TCT 2017

Academic Perspective on HBD

Presenter: Fumiaki Ikeno, Yuka Suzuki, Shigeru Saito

October 30, 2017

Presentation TCT 2017

Videotape Welcome and Comments From Alain Cribier

Presenter: Spencer B. King III, Patrick W. Serruys, Martin B. Leon

October 30, 2017

Presentation TCT 2017

Case #1: An Endovascular Option for an Untreatable Below-the-Ankle Occlusion

Presenter: Teguh Santoso, Yoshito Yamamoto, Hsuan-Li Huang

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey IV: The Hospital Experience

Presenter: Martina Kelly Speight, Sandra Lauck

October 30, 2017

Presentation TCT 2017

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Kiyohito Nakai

October 30, 2017

Presentation TCT 2017

Featured Lecture: The Enlightened History of PTCA: A Retrospective Tribute

Presenter: Spencer B. King III, Patrick W. Serruys, Philippe E. Gaspard

October 30, 2017

Presentation TCT 2017

FDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Bram D. Zuckerman

October 30, 2017

Presentation TCT 2017

Welcome and Comments From the New CEO of CRF: Goals and Vision

Presenter: Spencer B. King III, Patrick W. Serruys, Juan F. Granada

October 30, 2017

Presentation TCT 2017

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Wei-Hsian Yin

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Case #3: Rescue From Left Main Occlusion With Severe Aortic Stenosis

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Tetsuya Kaneko

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

Case #2: Rotablator Burr Stall - Finding a Solution When All Efforts Fail

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Linda Lison

October 30, 2017

Presentation TCT 2017

Case #1: How to Manage and Treat LM Bifurcation

Presenter: Jun-Jack Cheng, Wasan Udayachalerm

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey III: Behind the Scenes

Presenter: Martina Kelly Speight, Sarah Clarke

October 30, 2017

Advertisement

Bioresorbable Scaffolds in a Coronary CTO

Industry Perspective on HBD

Case #3: Double CTO in AMI With Cardiogenic Shock

TAVR Patient Journey V: Addressing Complications and Follow-up

Case #2: Wire Gone Weird

Academic Perspective on HBD

Videotape Welcome and Comments From Alain Cribier

Case #1: An Endovascular Option for an Untreatable Below-the-Ankle Occlusion

TAVR Patient Journey IV: The Hospital Experience

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

Featured Lecture: The Enlightened History of PTCA: A Retrospective Tribute

FDA Perspectives on HBD: Past, Present, and Future

Welcome and Comments From the New CEO of CRF: Goals and Vision

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Case #3: Rescue From Left Main Occlusion With Severe Aortic Stenosis

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Case #2: Rotablator Burr Stall - Finding a Solution When All Efforts Fail

Case #1: How to Manage and Treat LM Bifurcation

TAVR Patient Journey III: Behind the Scenes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content